Complement dependent cytotoxic autoantibodies in patients with acute leukaemia following fibrinolytic therapy by protease 1 of aspergillus oryzae.
D000328:Adult; D001230:Aspergillus / Q000201:enzymology; D001323:Autoantibodies; D001803:Blood Transfusion; D002648:Child; D002675:Child, Preschool; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000276:immunology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000627:therapeutic use*
D001323:Autoantibodies; D010447:Peptide Hydrolases